CSIMarket
 

Si bone inc   (SIBN)
Other Ticker:  
 

Si Bone Inc 's Working Capital Per Sales

SIBN's Working Capital and Revenue growth



SIBN Working Capital Per Revenue (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Y / Y Working Capital Change 62.76 % 60.71 % 58.3 % 47.16 % -23.06 %
Y / Y Revenue Change 15.77 % 21.28 % 28.53 % 28.93 % 45.76 %
Working Capital Per Revenue 1.33 1.25 1.18 1.11 1.04
Total Ranking # 2251 # 1921 # 2150 # 2702 # 2257
Seq. Working Capital Change -2.72 % -1.91 % -1.37 % 72.95 % -3.94 %
Seq. Revenue Change -2.29 % 14.07 % 2.99 % 0.85 % 2.36 %





Comment on SIBN's Working Capital Per Revenue in the first quarter 2024
Si Bone Inc 's Working Capital Per Revenue sequentially grew to 1.33 during the Q1 2024, below the Si Bone Inc average.

Within Healthcare sector 69 other companies have achieved lower Working Capital Per Revenue during the Q1 2024. While Working Capital Per Revenue total ranking has deteriorated in the first quarter 2024, compared to previous quarter from 1921 to 2251.
Working Capital Per Revenue Ranking
Within: No.
Industry # 18
Sector # 70
S&P 500 # 2251


Working Capital Per Revenue Statistics
High Average Low
3.86
1.87
1.03
(Jun 30 2020)   (Mar 31 2023)



Financial Statements
Si Bone Inc 's Working Capital $ 184 Millions Visit SIBN's Balance sheet
Si Bone Inc 's Revenues $ 38 Millions Visit SIBN's Income Statement
Where are SIBN's Sales coming from? Visit SIBN's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2024, within Healthcare Sector Working Capital Per Revenue
Dyadic International Inc  3.64 
Ocular Therapeutix Inc   3.62 
Omniab Inc   3.62 
Aclaris Therapeutics Inc   3.37 
Pacific Biosciences Of California Inc   3.28 
Travere Therapeutics Inc   3.28 
Xencor Inc  3.22 
Ainos Inc   3.17 
Arcus Biosciences Inc   3.16 
Butterfly Network Inc   3.06 
Rhythm Pharmaceuticals inc   3.06 
Theravance Biopharma inc   2.95 
Arcutis Biotherapeutics Inc   2.86 
2seventy Bio Inc   2.83 
Ionis Pharmaceuticals Inc   2.83 
Zai Lab Limited  2.71 
Nurix Therapeutics Inc   2.46 
Cvrx inc   2.41 
Dariohealth Corp   2.39 
Schrodinger Inc   2.34 
Ocuphire Pharma Inc   2.30 
Cybin Inc   2.24 
Cryoport inc   2.24 
Vanda Pharmaceuticals Inc   2.24 
Zevra Therapeutics Inc   2.20 
Voyager Therapeutics Inc   2.16 
Blueprint Medicines Corporation  2.10 
Bionano Genomics Inc   2.09 
Utah Medical Products Inc  2.02 
Hookipa Pharma inc   2.00 
Date modified: 2024-05-08T16:50:21+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com